These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15178715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial.
    Ouriel K, Castaneda F, McNamara T, Swischuk J, Tepe G, Smith JJ, Clark J, Duda S.
    J Vasc Interv Radiol; 2004 Mar; 15(3):229-38. PubMed ID: 15028807
    [Abstract] [Full Text] [Related]

  • 4. Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis--APART trial.
    Tepe G, Hopfenzitz C, Dietz K, Wiskirchen J, Heller S, Ouriel K, Ziemer G, Claussen CD, Duda SH.
    Radiology; 2006 Jun; 239(3):892-900. PubMed ID: 16641342
    [Abstract] [Full Text] [Related]

  • 5. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K, Katzen B, Mewissen M, Flick P, Clair DG, Benenati J, McNamara TO, Gibbens D.
    J Vasc Interv Radiol; 2000 Jun; 11(7):849-54. PubMed ID: 10928520
    [Abstract] [Full Text] [Related]

  • 6. Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.
    Nakada MT, Montgomery MO, Nedelman MA, Guerrero JL, Cohen SA, Barnathan ES, Jordan RE.
    J Vasc Interv Radiol; 2004 Feb; 15(2 Pt 1):169-76. PubMed ID: 14963184
    [Abstract] [Full Text] [Related]

  • 7. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group.
    Circulation; 2000 Jun 20; 101(24):2788-94. PubMed ID: 10859283
    [Abstract] [Full Text] [Related]

  • 8. Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab.
    Drescher P, McGuckin J, Rilling WS, Crain MR.
    AJR Am J Roentgenol; 2003 May 20; 180(5):1385-91. PubMed ID: 12704056
    [Abstract] [Full Text] [Related]

  • 9. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
    Lincoff AM, Califf RM, Van de Werf F, Willerson JT, White HD, Armstrong PW, Guetta V, Gibler WB, Hochman JS, Bode C, Vahanian A, Steg PG, Ardissino D, Savonitto S, Bar F, Sadowski Z, Betriu A, Booth JE, Wolski K, Waller M, Topol EJ, Global Use of Strategies To Open Coronary Arteries Investigators (GUSTO).
    JAMA; 2002 Nov 06; 288(17):2130-5. PubMed ID: 12413372
    [Abstract] [Full Text] [Related]

  • 10. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
    Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C, Nekolla SG, Seyfarth M, Martinoff S, Markwardt C, Clermont G, Gerbig HW, Leiss J, Schwaiger M, Schömig A, Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators.
    JAMA; 2004 Feb 25; 291(8):947-54. PubMed ID: 14982910
    [Abstract] [Full Text] [Related]

  • 11. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
    Simpson D, Siddiqui MA, Scott LJ, Hilleman DE.
    Am J Cardiovasc Drugs; 2006 Feb 25; 6(4):265-85. PubMed ID: 16913828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single center experience with provisional abciximab therapy in complex lower limb interventions.
    Keo H, Diehm N, Baumgartner R, Husmann M, Baumgartner I.
    Vasa; 2008 Aug 25; 37(3):257-64. PubMed ID: 18690593
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.
    Peter K, Kohler B, Straub A, Ruef J, Moser M, Nordt T, Olschewski M, Ohman ME, Kübler W, Bode C.
    Circulation; 2000 Sep 26; 102(13):1490-6. PubMed ID: 11004138
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.